Your browser doesn't support javascript.
loading
Comparison of long-term oncologic outcomes of central lumpectomy and conventional breast-conserving surgery for invasive breast cancer: propensity score matching analysis.
Jung, Ji-Jung; Cheun, Jong-Ho; Kim, Hong-Kyu; Lee, Han-Byoel; Moon, Hyeong-Gon; Hwang, Ki-Tae; Han, Wonshik.
Afiliação
  • Jung JJ; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
  • Cheun JH; Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • Kim HK; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
  • Lee HB; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
  • Moon HG; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
  • Hwang KT; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
  • Han W; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
Breast Cancer Res Treat ; 205(3): 465-474, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38526688
ABSTRACT

PURPOSE:

Central lumpectomy (CL) is a breast-conserving surgical (BCS) technique that involves excision of the nipple-areolar complex with breast tumor in centrally located breast cancers. We aimed to investigate the long-term clinical outcomes of CL in comparison with conventional BCS (cBCS).

METHODS:

Patient records who underwent BCS with clear resection margins for invasive breast cancer between 2004 and 2018 were retrospectively reviewed. Of the total 6,533 patients, 106 (1.6%) underwent CL. Median follow-up duration was 73.4 months. 13 propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) were used to minimize selection bias.

RESULTS:

The CL group showed a significantly higher ipsilateral breast tumor recurrence (IBTR) rate than the cBCS group (10-year IBTR rate 5.8% vs. 3.1%, p = 0.004), even after adjusting for other variables (hazard ratio (HR), 2.65; 95% confidence interval (CI), 1.07-6.60, p = 0.048). However, there were no significant differences observed in regional recurrence, distant metastasis, or overall survival rates between the two groups. Both PSM and IPTW analyses showed significantly higher IBTR in the CL group (PSM HR, 3.27; 95% CI, 0.94-11.36; p = 0.048 and IPTW HR, 4.66; 95%CI, 1.85-11.77; p < 0.001). Lastly, when analyzing 2,213 patients whose tumors were located within 3 cm of the nipple, the CL group showed a significantly higher IBTR than the cBCS group before and after PSM.

CONCLUSION:

CL was associated with a higher rate of IBTR compared to cBCS, while other survival outcomes were comparable. For centrally located tumors, CL may be considered for patients preferring breast preservation. However, higher risk for IBTR should be informed and careful surveillance may be necessary during the early post-operative follow-up periods.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mastectomia Segmentar / Pontuação de Propensão / Recidiva Local de Neoplasia Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mastectomia Segmentar / Pontuação de Propensão / Recidiva Local de Neoplasia Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article